Trajectory of white matter hyperintensity burden preceding mild cognitive impairment

To determine the time of acceleration in white matter hyperintensity (WMH) burden, a common indicator of cerebrovascular pathology, in relation to conversion to mild cognitive impairment (MCI) in the elderly. A total of 181 cognitively intact elderly volunteers from the longitudinal, prospective, Or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2012-08, Vol.79 (8), p.741-747
Hauptverfasser: SILBERT, Lisa C, DODGE, Hiroko H, PERKINS, Louie G, SHERBAKOV, Lena, LAHNA, David, ERTEN-LYONS, Deniz, WOLTJER, Randall, SHINTO, Lynne, KAYE, Jeffrey A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 747
container_issue 8
container_start_page 741
container_title Neurology
container_volume 79
creator SILBERT, Lisa C
DODGE, Hiroko H
PERKINS, Louie G
SHERBAKOV, Lena
LAHNA, David
ERTEN-LYONS, Deniz
WOLTJER, Randall
SHINTO, Lynne
KAYE, Jeffrey A
description To determine the time of acceleration in white matter hyperintensity (WMH) burden, a common indicator of cerebrovascular pathology, in relation to conversion to mild cognitive impairment (MCI) in the elderly. A total of 181 cognitively intact elderly volunteers from the longitudinal, prospective, Oregon Brain Aging Study underwent yearly evaluations, including brain MRI, and cognitive testing. MRIs were analyzed for imaging markers of neurodegeneration: WMH and ventricular CSF (vCSF) volumes. The time before MCI, when the changes in WMH and vCSF burden accelerate, was assessed using a mixed-effects model with a change point for subjects who developed MCI during follow-up. During a follow-up duration of up to 19.6 years, 134 subjects converted to MCI. Acceleration in %WMH volume increase occurred 10.6 years before MCI onset. On average, the annual rate of change in %WMH increased an additional 3.3% after the change point. Acceleration in %vCSF volume increase occurred 3.7 years before the onset of MCI. Out of 63 subjects who converted to MCI and had autopsy, only 28.5% had Alzheimer disease (AD) as the sole etiology of their dementia, while almost just as many (24%) had both AD and significant ischemic cerebrovascular disease present. Acceleration in WMH burden, a common indicator of cerebrovascular disease in the elderly, is a pathologic change that emerges early in the presymptomatic phase leading to MCI. Longitudinal changes in WMH may thus be useful in determining those at risk for cognitive impairment and for planning strategies for introducing disease-modifying therapies prior to dementia onset.
doi_str_mv 10.1212/wnl.0b013e3182661f2b
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421153</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1291607106</sourcerecordid><originalsourceid>FETCH-LOGICAL-c537t-1eb4018d759e74d449d626694160e6c979ef79a4dc98b098e8cbc93c6f88f9fe3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhHyDkCxKXFH_FsS9IqCof0qq9LIKb5TjjXVeJE2xvq_33GHUp0EtPc5hn3pl3XoReU3JGGWXvb-N4RnpCOXCqmJTUs_4JWtGWyUZy9uMpWhHCVMNVp07Qi5yvCanNTj9HJ4wpwZlkK7TZJHsNrszpgGePb3ehAJ5sKZDw7rBACrFAzKEccL9PA0S8JHAwhLjFUxgH7OZtDCXcAA7TYkOaIJaX6Jm3Y4ZXx3qKvn262Jx_adZXn7-ef1w3ruVdaSj0glA1dK2GTgxC6EFWI1pQSUA63WnwnbZicFr1RCtQrneaO-mV8toDP0Uf7nSXfT_B4OrqZEezpDDZdDCzDeb_Tgw7s51vDBeM0pZXgXdHgTT_3EMuZgrZwTjaCPM-G8p0vaWjRD6OEt5SIup_KyruUJfmnBP4-4soMb-zM98v1-ZhdnXszb9u7of-hFWBt0fAZmdHn2x0If_lJFOStB3_Bfb3pbo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035104279</pqid></control><display><type>article</type><title>Trajectory of white matter hyperintensity burden preceding mild cognitive impairment</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>SILBERT, Lisa C ; DODGE, Hiroko H ; PERKINS, Louie G ; SHERBAKOV, Lena ; LAHNA, David ; ERTEN-LYONS, Deniz ; WOLTJER, Randall ; SHINTO, Lynne ; KAYE, Jeffrey A</creator><creatorcontrib>SILBERT, Lisa C ; DODGE, Hiroko H ; PERKINS, Louie G ; SHERBAKOV, Lena ; LAHNA, David ; ERTEN-LYONS, Deniz ; WOLTJER, Randall ; SHINTO, Lynne ; KAYE, Jeffrey A</creatorcontrib><description>To determine the time of acceleration in white matter hyperintensity (WMH) burden, a common indicator of cerebrovascular pathology, in relation to conversion to mild cognitive impairment (MCI) in the elderly. A total of 181 cognitively intact elderly volunteers from the longitudinal, prospective, Oregon Brain Aging Study underwent yearly evaluations, including brain MRI, and cognitive testing. MRIs were analyzed for imaging markers of neurodegeneration: WMH and ventricular CSF (vCSF) volumes. The time before MCI, when the changes in WMH and vCSF burden accelerate, was assessed using a mixed-effects model with a change point for subjects who developed MCI during follow-up. During a follow-up duration of up to 19.6 years, 134 subjects converted to MCI. Acceleration in %WMH volume increase occurred 10.6 years before MCI onset. On average, the annual rate of change in %WMH increased an additional 3.3% after the change point. Acceleration in %vCSF volume increase occurred 3.7 years before the onset of MCI. Out of 63 subjects who converted to MCI and had autopsy, only 28.5% had Alzheimer disease (AD) as the sole etiology of their dementia, while almost just as many (24%) had both AD and significant ischemic cerebrovascular disease present. Acceleration in WMH burden, a common indicator of cerebrovascular disease in the elderly, is a pathologic change that emerges early in the presymptomatic phase leading to MCI. Longitudinal changes in WMH may thus be useful in determining those at risk for cognitive impairment and for planning strategies for introducing disease-modifying therapies prior to dementia onset.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/wnl.0b013e3182661f2b</identifier><identifier>PMID: 22843262</identifier><identifier>CODEN: NEURAI</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Aged ; Aged, 80 and over ; Biological and medical sciences ; Brain - pathology ; Cerebrospinal Fluid - metabolism ; Cognitive Dysfunction - cerebrospinal fluid ; Cognitive Dysfunction - diagnosis ; Cognitive Dysfunction - pathology ; Disease Progression ; Early Diagnosis ; Female ; Geriatric Assessment - methods ; Humans ; Magnetic Resonance Imaging - methods ; Male ; Medical sciences ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Nerve Fibers, Myelinated - pathology ; Neuroimaging - methods ; Neurology ; Time Factors</subject><ispartof>Neurology, 2012-08, Vol.79 (8), p.741-747</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 by AAN Enterprises, Inc. 2012 AAN Enterprises, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c537t-1eb4018d759e74d449d626694160e6c979ef79a4dc98b098e8cbc93c6f88f9fe3</citedby><cites>FETCH-LOGICAL-c537t-1eb4018d759e74d449d626694160e6c979ef79a4dc98b098e8cbc93c6f88f9fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26286057$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22843262$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SILBERT, Lisa C</creatorcontrib><creatorcontrib>DODGE, Hiroko H</creatorcontrib><creatorcontrib>PERKINS, Louie G</creatorcontrib><creatorcontrib>SHERBAKOV, Lena</creatorcontrib><creatorcontrib>LAHNA, David</creatorcontrib><creatorcontrib>ERTEN-LYONS, Deniz</creatorcontrib><creatorcontrib>WOLTJER, Randall</creatorcontrib><creatorcontrib>SHINTO, Lynne</creatorcontrib><creatorcontrib>KAYE, Jeffrey A</creatorcontrib><title>Trajectory of white matter hyperintensity burden preceding mild cognitive impairment</title><title>Neurology</title><addtitle>Neurology</addtitle><description>To determine the time of acceleration in white matter hyperintensity (WMH) burden, a common indicator of cerebrovascular pathology, in relation to conversion to mild cognitive impairment (MCI) in the elderly. A total of 181 cognitively intact elderly volunteers from the longitudinal, prospective, Oregon Brain Aging Study underwent yearly evaluations, including brain MRI, and cognitive testing. MRIs were analyzed for imaging markers of neurodegeneration: WMH and ventricular CSF (vCSF) volumes. The time before MCI, when the changes in WMH and vCSF burden accelerate, was assessed using a mixed-effects model with a change point for subjects who developed MCI during follow-up. During a follow-up duration of up to 19.6 years, 134 subjects converted to MCI. Acceleration in %WMH volume increase occurred 10.6 years before MCI onset. On average, the annual rate of change in %WMH increased an additional 3.3% after the change point. Acceleration in %vCSF volume increase occurred 3.7 years before the onset of MCI. Out of 63 subjects who converted to MCI and had autopsy, only 28.5% had Alzheimer disease (AD) as the sole etiology of their dementia, while almost just as many (24%) had both AD and significant ischemic cerebrovascular disease present. Acceleration in WMH burden, a common indicator of cerebrovascular disease in the elderly, is a pathologic change that emerges early in the presymptomatic phase leading to MCI. Longitudinal changes in WMH may thus be useful in determining those at risk for cognitive impairment and for planning strategies for introducing disease-modifying therapies prior to dementia onset.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Brain - pathology</subject><subject>Cerebrospinal Fluid - metabolism</subject><subject>Cognitive Dysfunction - cerebrospinal fluid</subject><subject>Cognitive Dysfunction - diagnosis</subject><subject>Cognitive Dysfunction - pathology</subject><subject>Disease Progression</subject><subject>Early Diagnosis</subject><subject>Female</subject><subject>Geriatric Assessment - methods</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Nerve Fibers, Myelinated - pathology</subject><subject>Neuroimaging - methods</subject><subject>Neurology</subject><subject>Time Factors</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhHyDkCxKXFH_FsS9IqCof0qq9LIKb5TjjXVeJE2xvq_33GHUp0EtPc5hn3pl3XoReU3JGGWXvb-N4RnpCOXCqmJTUs_4JWtGWyUZy9uMpWhHCVMNVp07Qi5yvCanNTj9HJ4wpwZlkK7TZJHsNrszpgGePb3ehAJ5sKZDw7rBACrFAzKEccL9PA0S8JHAwhLjFUxgH7OZtDCXcAA7TYkOaIJaX6Jm3Y4ZXx3qKvn262Jx_adZXn7-ef1w3ruVdaSj0glA1dK2GTgxC6EFWI1pQSUA63WnwnbZicFr1RCtQrneaO-mV8toDP0Uf7nSXfT_B4OrqZEezpDDZdDCzDeb_Tgw7s51vDBeM0pZXgXdHgTT_3EMuZgrZwTjaCPM-G8p0vaWjRD6OEt5SIup_KyruUJfmnBP4-4soMb-zM98v1-ZhdnXszb9u7of-hFWBt0fAZmdHn2x0If_lJFOStB3_Bfb3pbo</recordid><startdate>20120821</startdate><enddate>20120821</enddate><creator>SILBERT, Lisa C</creator><creator>DODGE, Hiroko H</creator><creator>PERKINS, Louie G</creator><creator>SHERBAKOV, Lena</creator><creator>LAHNA, David</creator><creator>ERTEN-LYONS, Deniz</creator><creator>WOLTJER, Randall</creator><creator>SHINTO, Lynne</creator><creator>KAYE, Jeffrey A</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20120821</creationdate><title>Trajectory of white matter hyperintensity burden preceding mild cognitive impairment</title><author>SILBERT, Lisa C ; DODGE, Hiroko H ; PERKINS, Louie G ; SHERBAKOV, Lena ; LAHNA, David ; ERTEN-LYONS, Deniz ; WOLTJER, Randall ; SHINTO, Lynne ; KAYE, Jeffrey A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c537t-1eb4018d759e74d449d626694160e6c979ef79a4dc98b098e8cbc93c6f88f9fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Brain - pathology</topic><topic>Cerebrospinal Fluid - metabolism</topic><topic>Cognitive Dysfunction - cerebrospinal fluid</topic><topic>Cognitive Dysfunction - diagnosis</topic><topic>Cognitive Dysfunction - pathology</topic><topic>Disease Progression</topic><topic>Early Diagnosis</topic><topic>Female</topic><topic>Geriatric Assessment - methods</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Nerve Fibers, Myelinated - pathology</topic><topic>Neuroimaging - methods</topic><topic>Neurology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SILBERT, Lisa C</creatorcontrib><creatorcontrib>DODGE, Hiroko H</creatorcontrib><creatorcontrib>PERKINS, Louie G</creatorcontrib><creatorcontrib>SHERBAKOV, Lena</creatorcontrib><creatorcontrib>LAHNA, David</creatorcontrib><creatorcontrib>ERTEN-LYONS, Deniz</creatorcontrib><creatorcontrib>WOLTJER, Randall</creatorcontrib><creatorcontrib>SHINTO, Lynne</creatorcontrib><creatorcontrib>KAYE, Jeffrey A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SILBERT, Lisa C</au><au>DODGE, Hiroko H</au><au>PERKINS, Louie G</au><au>SHERBAKOV, Lena</au><au>LAHNA, David</au><au>ERTEN-LYONS, Deniz</au><au>WOLTJER, Randall</au><au>SHINTO, Lynne</au><au>KAYE, Jeffrey A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trajectory of white matter hyperintensity burden preceding mild cognitive impairment</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2012-08-21</date><risdate>2012</risdate><volume>79</volume><issue>8</issue><spage>741</spage><epage>747</epage><pages>741-747</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><coden>NEURAI</coden><abstract>To determine the time of acceleration in white matter hyperintensity (WMH) burden, a common indicator of cerebrovascular pathology, in relation to conversion to mild cognitive impairment (MCI) in the elderly. A total of 181 cognitively intact elderly volunteers from the longitudinal, prospective, Oregon Brain Aging Study underwent yearly evaluations, including brain MRI, and cognitive testing. MRIs were analyzed for imaging markers of neurodegeneration: WMH and ventricular CSF (vCSF) volumes. The time before MCI, when the changes in WMH and vCSF burden accelerate, was assessed using a mixed-effects model with a change point for subjects who developed MCI during follow-up. During a follow-up duration of up to 19.6 years, 134 subjects converted to MCI. Acceleration in %WMH volume increase occurred 10.6 years before MCI onset. On average, the annual rate of change in %WMH increased an additional 3.3% after the change point. Acceleration in %vCSF volume increase occurred 3.7 years before the onset of MCI. Out of 63 subjects who converted to MCI and had autopsy, only 28.5% had Alzheimer disease (AD) as the sole etiology of their dementia, while almost just as many (24%) had both AD and significant ischemic cerebrovascular disease present. Acceleration in WMH burden, a common indicator of cerebrovascular disease in the elderly, is a pathologic change that emerges early in the presymptomatic phase leading to MCI. Longitudinal changes in WMH may thus be useful in determining those at risk for cognitive impairment and for planning strategies for introducing disease-modifying therapies prior to dementia onset.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>22843262</pmid><doi>10.1212/wnl.0b013e3182661f2b</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2012-08, Vol.79 (8), p.741-747
issn 0028-3878
1526-632X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421153
source Journals@Ovid Ovid Autoload; MEDLINE; Alma/SFX Local Collection
subjects Aged
Aged, 80 and over
Biological and medical sciences
Brain - pathology
Cerebrospinal Fluid - metabolism
Cognitive Dysfunction - cerebrospinal fluid
Cognitive Dysfunction - diagnosis
Cognitive Dysfunction - pathology
Disease Progression
Early Diagnosis
Female
Geriatric Assessment - methods
Humans
Magnetic Resonance Imaging - methods
Male
Medical sciences
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Nerve Fibers, Myelinated - pathology
Neuroimaging - methods
Neurology
Time Factors
title Trajectory of white matter hyperintensity burden preceding mild cognitive impairment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A11%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trajectory%20of%20white%20matter%20hyperintensity%20burden%20preceding%20mild%20cognitive%20impairment&rft.jtitle=Neurology&rft.au=SILBERT,%20Lisa%20C&rft.date=2012-08-21&rft.volume=79&rft.issue=8&rft.spage=741&rft.epage=747&rft.pages=741-747&rft.issn=0028-3878&rft.eissn=1526-632X&rft.coden=NEURAI&rft_id=info:doi/10.1212/wnl.0b013e3182661f2b&rft_dat=%3Cproquest_pubme%3E1291607106%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035104279&rft_id=info:pmid/22843262&rfr_iscdi=true